Cell Source Inc (PK) (CLCS)

Cell Source Presented Its Breakthrough Developments for Mismatched Donor Stem Cell and Organ Transplants and Off-the-shelf CAR-T Cell Therapy at the LD Micro Invitational Conference in Los Angeles This Week

Plans to expand clinical program and uplist to the NASDAQ were also presented. NEW YORK, NY / ACCESS Newswire / May 21, 2026 / Cell Source, Inc...

Cell Source, Inc. to Present at the LD Micro Invitational XVI

New York, New York--(Newsfile Corp. - May 14, 2026) - Cell Source, Inc. (OTC Pink: CLCS) announced today that it will be participating in the 16th...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Cell Source Announces Closing of Private Placement and Hiring of Transfer Agent

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 15, 2026 / Cell Source, Inc. (OTC Pink Limited:CLCS) ("Cell Source" or the...

Form 15-12G - Securities registration termination [Section 12(g)]

Form 8-K - Current report

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form D - Notice of Exempt Offering of Securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]